Can you provide the last earnings date for NEUROSENSE THERAPEUTICS LTD?
NEUROSENSE THERAPEUTICS LTD (NRSN) last reported earnings on 2/26/2026.
NASDAQ:NRSN • IL0011809592
Past quarterly earnings results for NEUROSENSE THERAPEUTICS LTD (NRSN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | -0.19 | - | -869.00% | - | - | |||
| Q1 2025 | -0.14 | - | 60.66% | - | - | |||
| Q4 2024 | -0.06 | -0.12 | 48.85% | 62.50% | - | - | ||
| Q3 2024 | -0.11 | -0.16 | 32.60% | -210.00% | - | - | ||
| Q2 2024 | -0.02 | -0.20 | 90.20% | 95.45% | - | - | ||
| Q1 2024 | -0.35 | -0.21 | -67.38% | - | - | - | ||
| Q4 2023 | -0.16 | -0.20 | 21.57% | - | - | - | ||
| Q3 2023 | 0.10 | -0.25 | 140.02% | - | - | - | ||
| Q2 2023 | -0.44 | -0.29 | -54.06% | -41.94% | - | - | ||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | - | - | - | - | ||||
| Q3 2022 | - | - | - | - | ||||
| Q2 2022 | -0.31 | - | - | - | - | |||
| Q1 2022 | -0.24 | -0.18 | -30.72% | - | - | - | ||
| Q4 2021 | -0.16 | - | - | - | - | |||
| Q3 2021 | -0.24 | -0.21 | -12.04% | - | - | - | ||
| Q2 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - |
Notes
NEUROSENSE THERAPEUTICS LTD (NRSN) last reported earnings on 2/26/2026.
NEUROSENSE THERAPEUTICS LTD (NRSN) missed EPS estimates and missed revenue estimates in the most recent quarter.